COVID-19, leading to different treatment options for patients depending on where they live.On Friday, a World Health Organization guidelines panel advised against using the antiviral remdesivir for hospitalized patients, saying there’s no evidence it improves survival or avoids the need for breathing machines.
Pfizer applies for emergency coronavirus vaccine approval in U.S. But in the U.S. and many other countries, the drug has been the standard of care since a major, government-led study found other benefits — it shortened recovery time for hospitalized patients by five days on average, from 15 days to 10.Within the U.S., a federal guidelines panel and some leading medical groups have not endorsed two other therapies the Food and Drug.